Skip Nav Destination
Issues
1 July 2012
-
Cover Image
Cover Image
Silencing of marginal zone B and B1 cell-specific protein (MZB1), a novel tumor suppressor gene for hepatoma, through CpG island methylation was independently associated with a worse outcome of patients with hepatocellular carcinoma, and restoration of MZB1 expression in hepatoma cells reduced cell proliferation in vitro and in vivo. Distribution of ectopically expressed FLAG-tagged MZB1 in HepG2 cells is shown by immunofluorescence analysis (red). An endoplasmic reticulum marker (Calnexin) and nuclei are also shown in green and blue (DAPI), respectively. For details, see the article by Matsumura and colleagues on page 3541 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR New Strategies
CCR Drug Updates
Molecular Pathways
Review
Human Cancer Biology
Cancer Therapy: Preclinical
Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors
Margaret M. Centenera; Joanna L. Gillis; Adrienne R. Hanson; Shalini Jindal; Renea A. Taylor; Gail P. Risbridger; Peter D. Sutherland; Howard I. Scher; Ganesh V. Raj; Karen E. Knudsen; Trina Yeadon; for the Australian Prostate Cancer BioResource; Wayne D. Tilley; Lisa M. Butler
Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells
Tadaaki Yamada; Shinji Takeuchi; Junya Nakade; Kenji Kita; Takayuki Nakagawa; Shigeki Nanjo; Takahiro Nakamura; Kunio Matsumoto; Manabu Soda; Hiroyuki Mano; Toshimitsu Uenaka; Seiji Yano
LY2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF-β and BMP-Associated Proinflammatory and Proangiogenic Signals
Paul Flechsig; Monika Dadrich; Sebastian Bickelhaupt; Jürgen Jenne; Kai Hauser; Carmen Timke; Peter Peschke; Eric W. Hahn; Hermann-Josef Gröne; Jonathan Yingling; Michael Lahn; Ute Wirkner; Peter E. Huber
Imaging, Diagnosis, Prognosis
Differential Expression of 2′,3′-Cyclic-Nucleotide 3′-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survival
Michael Zorniak; Paul A. Clark; Heather E. Leeper; Matthew D. Tipping; David M. Francis; Kevin R. Kozak; M. Shahriar Salamat; John S. Kuo
Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy
Andrea Salonia; Firas Abdollah; Umberto Capitanio; Nazareno Suardi; Alberto Briganti; Andrea Gallina; Renzo Colombo; Matteo Ferrari; Giulia Castagna; Patrizio Rigatti; Francesco Montorsi
Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
Jin Sung Jang; Hyo-Sung Jeon; Zhifu Sun; Marie Christine Aubry; Hui Tang; Cheol-Hong Park; Fariborz Rakhshan; Debra A. Schultz; Christopher P. Kolbert; Ruth Lupu; Jae Yong Park; Curtis C. Harris; Ping Yang; Jin Jen
Cancer Therapy: Clinical
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada; Toshiaki Yoshikawa; Daisuke Nobuoka; Hirofumi Shirakawa; Toshimitsu Kuronuma; Yutaka Motomura; Shoichi Mizuno; Hiroshi Ishii; Kohei Nakachi; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Naoto Gotohda; Tadatoshi Takayama; Kenji Yamao; Katsuhiko Uesaka; Junji Furuse; Taira Kinoshita; Tetsuya Nakatsura
Predictive Biomarkers and Personalized Medicine
Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Carlos Fernández de Larrea; Alfons Navarro; Rut Tejero; Natalia Tovar; Tania Díaz; María Teresa Cibeira; Laura Rosiñol; Gerardo Ferrer; Montserrat Rovira; María Rozman; Mariano Monzó; Joan Bladé
Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention
Michelle A.T. Hildebrandt; Scott M. Lippman; Carol J. Etzel; Edward Kim; J. Jack Lee; Fadlo R. Khuri; Margaret R. Spitz; Reuben Lotan; Waun Ki Hong; Xifeng Wu
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.